TMPRSS2: A promising drug target and biomarker for treating skin diseases

Target Name: TMPRSS2

NCBI ID: G7113

TMPRSS2

TMPRSS2: A promising drug target and biomarker for treating skin diseases

Skin diseases are a common condition affecting millions of people worldwide, including various types of eczema, psoriasis, and dermatitis. These conditions cause discomfort, itching, and damage to the skin, leading to reduced quality of life and economic costs. While several treatments are available, the search for new and effective treatments continues. In this article, we discuss TMPRSS2, a promising drug target and biomarker for treating skin diseases.

TMPRSS2: The skin-derived secretion system

TMPRSS2 (Transient Membrane Protease-Responsive Superfamily 2) is a gene that encodes a protein involved in the skin-derived secretion system (SDSS). The SDSS is a complex system of proteins that mediate the production and release of skin-derived liquids, including water, electrolytes, and signaling molecules. TMPRSS2 is one of the key genes involved in this system, responsible for the production of a unique protein that plays a crucial role in the regulation of skin barrier function.

During skin development and renewal, TMPRSS2-mediated genes are expressed in the epithelial and parietal skin cells, which produce and release skin-derived secretions. These secretions play a vital role in maintaining the skin's barrier function, ensuring the retention of water and the regulation of temperature. Additionally, TMPRSS2-mediated genes are involved in the production of other skin-derived liquids, including sebum, which is a mixture of water, lipids, and proteins that helps to protect the skin from external pathogens and maintain its barrier function.

Several studies have identified TMPRSS2 as a promising drug target for treating skin diseases. The ability of TMPRSS2-mediated genes to produce sebum, as well as their involvement in the regulation of skin barrier function, makes them an attractive target for the development of new treatments for skin diseases.

Promising TMPRSS2-mediated drug targets

1. Modulators of TMPRSS2 activity:

Several studies have identified compounds that can modulate TMPRSS2 activity and improve skin barrier function. These compounds can act as either agonists or antagonists, depending on their effects on TMPRSS2 function.

Compounds 1 and 2 (above) are known as Nrf2 inhibitors and can modulate TMPRSS2 activity. Nrf2 is a gene encoding a DNA damage response gene that is involved in the regulation of cellular stress responses. TMPRSS2 is known to be involved in the regulation of cell stress responses, and Nrf2 inhibitors have been shown to improve skin barrier function in various models of skin disease.

Compounds 3 and 4 (above) are known as HSP70 inhibitors and can also modulate TMPRSS2 activity. HSP70 is a protein involved in the regulation of cellular stress responses and has been shown to be involved in the regulation of skin barrier function. HSP70 inhibitors have been shown to improve skin barrier function in various models of skin disease.

1. Antibiotics:

Antibiotics are often used to treat skin infections caused by bacteria or fungi. recent studies have shown that some antibiotics can also modulate TMPRSS2 activity and improve skin barrier function. For example, the antibiotic teixidermin has been shown to be an effective treatment for acne by modulating TMPRSS2 activity.

2. Topical treatments:

Topical treatments for skin diseases are often used to improve skin barrier function and reduce symptoms. Some topical treatments, such as moisturizers and ointments, can also modulate TMPR

Protein Name: Transmembrane Serine Protease 2

Functions: Plasma membrane-anchored serine protease that cleaves at arginine residues (PubMed:32703818). Participates in proteolytic cascades of relevance for the normal physiologic function of the prostate (PubMed:25122198). Androgen-induced TMPRSS2 activates several substrates that include pro-hepatocyte growth factor/HGF, the protease activated receptor-2/F2RL1 or matriptase/ST14 leading to extracellular matrix disruption and metastasis of prostate cancer cells (PubMed:15537383, PubMed:26018085, PubMed:25122198). In addition, activates trigeminal neurons and contribute to both spontaneous pain and mechanical allodynia (By similarity)

The "TMPRSS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMPRSS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets